Approval · Notice of Compliance 9493 · 2008
ACTIVELLE LD: Notice of Compliance 9493
Issued April 18, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9493
- Date
- April 18, 2008
- Company
- Novo Nordisk Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength
- Therapeutic class
- Estrogenic hormones / progestin
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACTIVELLE LD | 02309009 | Marketed |
Medicinal ingredients
- ESTRADIOL 0.5 MG per TAB
- NORETHINDRONE ACETATE 0.1 MG per TAB